|
Q3 FY2024
As of Jun 30, 2024
|
Q2 FY2024
As of Mar 31, 2024
|
Q1 FY2024
As of Dec 31, 2023
|
Q4 FY2023
As of Sep 30, 2023
|
Q3 FY2023
As of Jun 30, 2023
|
Q2 FY2023
As of Mar 31, 2023
|
Q1 FY2023
As of Dec 31, 2022
|
|
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current Assets | |||||||
| Cash | |||||||
| Prepaid expenses | |||||||
| Investments held in trust account | |||||||
| Deferred offering costs associated with initial public offering | |||||||
| Total Assets | |||||||
| LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIT) | |||||||
| Current Liabilities | |||||||
| Accrued expenses | |||||||
| Note payable - related party | |||||||
| Forward Purchase Agreement liability | |||||||
| Total current liabilities | |||||||
| Total Liabilities | |||||||
| Ordinary shares subject to possible redemption, 2,081,432 and 6,900,000 shares, respectively, at redemption value of $10.97 and $10.52 per share, respectively | |||||||
| SHAREHOLDERS' EQUITY (DEFICIT) | |||||||
| Ordinary shares, $0.000125 par value; 800,000,000 shares authorized; 2,392,000 shares issued and outstanding (1) | |||||||
| Additional paid-in capital | |||||||
| (Accumulated deficit)/retained earnings | |||||||
| Total Shareholders' Equity (Deficit) | |||||||
| Total Liabilities and Shareholders' Equity (Deficit) |
Loading...